ArticleBMJ open2020

Study protocol for a randomised controlled trial evaluating the effects of the orexin receptor antagonist suvorexant on sleep architecture and delirium in the intensive care unit.

Omid Azimaraghi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.